Upcoming Medical Conferences in Mesa
Feb 02 - 03, 2018 | Free | Medical Education
Level 2 Clinical Instructor Education And Credentialing Course is organized by A.T. Still University (ATSU) and will be held during Feb 02 - 03, 2018 at ASDOH Dental Clinic, Mesa, Arizona, United States of America. The Level 2 CCIP brings two constructs together in one professional development program that advances both clinical teaching and best practice when providing student clinical education. Using a case-based and interactive approach to education, this program will provide participants with the essential knowledge and skill to more effectively teach and mentor students in the context of a doctoring profession, across core areas of contemporary professional education and clinical practice that foster best clinical teaching and best practice in patient/client management. The program’s unique philosophy and design will enable clinical educators to achieve the best outcomes for student learning by concurrently advancing concepts of clinical teaching and clinical practice. The program is divided into three distinct parts: • Precourse assignments that include reading three articles and completing three of the online Professionalism Modules; • Advanced clinical instructor education via an interactive didactic course format that is appropriate to all physical therapist clinical educators; and • Assessment (credentialing) of curricula outcomes through an Assessment Center to apply information from the ACCIP. Additional details will be posted as soon as they are available.
Feb 14 - 15, 2018 | CME 13.30 | USD $650 | Research and Clinical Research
FDA Clinical Trial Requirements Regulations, Compliance and GCP Conference is organized by Society of Clinical Research Associates (SOCRA) and will be held during Feb 14 - 15, 2018 at Sheraton Mesa Hotel at Wrigleyville West, Mesa, Arizona, United States of America. This CME Conference has been approved for a maximum of 13.3 AMA PRA Category 1 Credits. Course Goal : SOCRA is pleased to offer this conference that is jointly sponsored with District/Regional offices of the U.S. Food and Drug Administration. This conference on FDA’s clinical trial requirements is designed to aid the Clinical Research Professional’s understanding of the mission, responsibilities and authority of the FDA and to facilitate interaction with FDA representatives. This two-day conference is intended to share information among FDA representatives and the regulated community, to facilitate the understanding of regulations, guidelines and practices, and to suggest methods and opportunities to enhance the research professional’s product development experience. The program will focus on the relationships among the FDA and clinical trial staff, investigators and IRBs. The workshop will highlight three areas that present challenges to sponsors and investigational sites: FDA Clinical Research Requirements, Enhancing Success through Communication and Financial Incentives, and Assuring Confidence in Clinical Research. Conference Objectives : Upon completion of the conference, the attendee should be able to: • Discuss the Role of the FDA District Offices, how they are Structured and their Responsibilities • Describe what FDA Expects in a Pharmaceutical Clinical Trial • Discuss the Science, Regulation and Assessment of Adverse Events • Discuss how Studies with Investigational Devices differ from those with Drugs and Biologics • Describe the Regulations that Apply to the Informed Consent Process • Discuss how the Ethical Principle of Justice underlies Responsible Participant Selection • Describe the IRB Regulations and FDA’s Mechanisms to Assure Compliance • Describe the Parameters included in Regulations Applying to Electronic Signatures • Describe how the FDA can assist members of the research community in their efforts to find information and understand FDA regulations. • Discuss the Responsibilities of the Clinical Investigator • Describe how Pre-IND Meetings and the FDA Meeting Process assist the Research Goal • Describe the Sponsor/Investigator’s Legal Responsibilities, Additional Duties and Concerns • Describe how the FDA’s Center for Biologics Regulates Research • Discuss the Array of Actions taken when Research Fails to Meet Standards Enforced by the FDA • Describe how the FDA’s Office of Science and Health Coordination, Good Clinical Practice Program, Promotes Confidence in Clinical Research Additional details will be posted as soon as they are available.